- Specialization
- Not classified
- Business
- Software Applications
- Market
- Healthcare
- Ecosystem
- Not applicable
- Customers
Consumersand 1 more customers valuesLess
- Enterprises
More details
- Organization type
- Commercial Company
- Ecosystem
- Not applicable
- Business
- Software Applications
- Specialization
- Not classified
- Market
- Healthcare
- Customers
- Consumers, Enterprises
- Delivery models
- Hosted Software
- Revenue models
- Subscription
- Listing status
- Not classified
- Latest equity round
- Seed
- Reported funding amount
- Not classified
About
Stellar Sleep builds a psychology-based mobile app and digital program for people with chronic insomnia, while also offering employee sleep programs to organizations. Its differentiation is a clinically backed approach focused on addressing insomnia’s underlying causes through structured behavioral modules rather than generic sleep advice.
Market
Stellar Sleep competes in consumer digital health and digital therapeutics for chronic insomnia, with an additional employer-sponsored sleep-benefits channel. It positions itself around clinically backed CBT-I and psychology-based personalization that addresses the underlying drivers of insomnia, rather than generic sleep-hygiene advice. Relative to Sleep Reset, Sleepio/SleepioRx, and Somryst, its differentiation is the combination of a direct-to-consumer mobile experience, personalized root-cause-oriented programming, short daily modules, and employer-focused ROI messaging.
Stellar Sleep primarily serves adults with chronic insomnia who want a structured, psychology-based alternative to generic sleep advice; its program requires participants to be at least 18. It also targets employers and employee-benefits decision-makers seeking a clinically backed sleep benefit for their workforce, particularly organizations concerned with absenteeism, productivity, and health costs.
At a Glance
Problem
Stellar Sleep addresses chronic insomnia, especially cases where people receive superficial advice such as cutting coffee or meditating even though their sleep problems may be driven by deeper psychological issues, including unresolved anxiety. The company frames the problem as affecting roughly 25 million Americans and focuses on breaking the insomnia cycle for people who need more than generic sleep tips. The main use case is an individual who repeatedly struggles to fall asleep or stay asleep and wants a psychology-based alternative to inadequate self-care advice.
The pain is both personal and economic: persistent poor sleep undermines daily life, while a paid program creates a meaningful affordability barrier. Stellar Sleep’s basic program starts at $188, with support materials describing a $188 monthly subscription and noting that the final cost varies by program and duration. The company offers financial assistance and says the service is eligible for FSA/HSA reimbursement, suggesting that access and out-of-pocket cost are important parts of the problem.
Product / Service
Stellar Sleep delivers cognitive behavioral therapy for insomnia, or CBT-I, through a mobile app available on iOS and Android. The program uses psychology rather than generic sleep hygiene alone, and its evidence-based sessions are designed to take only about five to ten minutes. The company positions CBT-I as the gold-standard treatment for insomnia and says its app helps users fall asleep faster, stay asleep longer, and improve their sleep permanently.
The delivery model is a paid digital program rather than an in-person clinic visit, making treatment available through a smartphone. Stellar Sleep reports that more than 80% of users see a dramatic improvement in their sleep in less than four weeks, while its broader positioning emphasizes helping users break the insomnia cycle through a structured, psychology-based intervention.
Market
Stellar Sleep competes in digital health, digital therapeutics, and sleep technology, specifically the digital CBT-I market. The available company and directory materials do not name direct competitors; the most visible alternatives described are generic sleep advice and other forms of inadequate care. Its differentiation is a focused insomnia product built around CBT-I and psychological causes rather than general wellness content.
The company shows meaningful early traction rather than appearing purely pre-revenue: its site reports thousands of users, more than 500 five-star reviews, Apple recognition as a top-ranked insomnia app, and awards including first place in the 2022 Digital Health Innovation Awards and Best Overall SleepTech Solution. Stellar Sleep began as a Harvard Innovation Labs venture in 2021, joined Y Combinator’s Summer 2023 batch, and received its first institutional funding in 2024 led by Initialized Capital with participation from several other investors. It has a paid subscription offer, but the available evidence does not disclose revenue, retention, or customer-acquisition figures.
Founders & Leadership
Funding History
Y Combinator
Initialized Capital
Recent News
The App Store listing describes wearable connectivity through Apple’s Health app, along with journaling features and a 30-night challenge.
MedShadow covered non-medication approaches to insomnia and referenced Stellar Sleep in its discussion of sleep restriction therapy, which matches sleep opportunity to a person’s ability to sleep.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Stellar Sleep primarily earns revenue through paid subscriptions to its digital sleep program; the basic program starts at $188, with pricing varying by program and duration. It also offers employer programs, creating an organizational benefits channel alongside direct-to-consumer subscriptions.